Keywords: promising, results, tezosentan, ahf, intravenous, dual, endothelin

Promising results with tezosentan in AHF

Article | 16 February 2001

• Print This

Tezosentan, an intravenous dual endothelin receptor antagonist indevelopment at Genentech and Actelion, has demonstrated positive hemodynamic results in its first ...

Enjoying this article? To continue reading you need to login or subscribe.